David C. Myles, CH. DISCOV. & NON-CLIN Development Officer at Olema Pharmaceuticals, Inc. (OLMA), sold 110,000 shares at $28.34 ($3.1M) on 2026-01-12, disclosed to the SEC on 2026-01-14.
Open-market sale of $3.1M OLMA by CH. DISCOV. & NON-CLIN Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.34 | 10,000 | $283K | 9.1% |
| 2 | $27.60 | 49,800 | $1.4M | 44.2% |
| 3 | $28.49 | 200 | $6K | 0.2% |
| 4 | $28.60 | 14,997 | $429K | 13.8% |
| 5 | $28.99 | 35,003 | $1.0M | 32.7% |
| Total | $28.25 avg | 110,000 |
| $3.1M |
| 100% |
| Filing → |
| OLMA | SELL | 2023-11-22 | $389K | — | Filing → |
| OLMA | SELL | 2023-11-13 | $4K | — | Filing → |
| OLMA | SELL | 2023-11-03 | $312K | — | Filing → |